Skip to content
healthcare.dev

Naloxone Hydrochloride

NDC 76045-114, NALOXONE HYDROCHLORIDE, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
76045-114
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213573
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76045-114 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NALOXONE HYDROCHLORIDE.4 mg/mL

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]

Package NDCNDC-11Package
76045-114-107604501141024 SYRINGE in 1 CARTON (76045-114-10) / 1 mL in 1 SYRINGE (76045-114-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/201fdedf-1736-4e52-9d7d-de14292547fd
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=76045-114

Use it

Look up 76045-114 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76045-114 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76045-114. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.